Innovotech Inc. Subsidiary, MBEC BioProducts Inc. Receives $150,000 Phase 2 Technology Commercialization Award

EDMONTON, ALBERTA--(CCNMatthews - May 10, 2006) - Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that its subsidiary, MBEC BioProducts Inc. has received a $150,000 Phase 2 Technology Commercialization Award from Alberta Heritage Foundation for Medical Research (AHFMR). The funds will be directly used to augment the development of the company's next product, a diagnostic susceptibility assay for determining antibiotic selection in a bacterial biofilm infection.

Back to news